Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Neil R. Miller, MD
Healthcare Professional Professor
Wilmer Eye Institute
The Johns Hopkins Hospital
600 N. Wolfe Street
Baltimore, Maryland, United States
Neil R. Miller is Professor of Ophthalmology, Neurology & Neurosurgery. He is also the Frank B. Walsh Professor of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmology and orbital disease.
Dr. Miller received his medical degree from the Johns Hopkins University School of Medicine and completed his residency in ophthalmology at the Wilmer Eye Institute, where he also served as chief resident. He completed a fellowship in neuro-ophthalmology at the University of California, San Francisco. He is board certified in ophthalmology and has been a member of the Wilmer faculty since 1976.
Dr. Miller has an expertise in neuro-ophthalmology, ophthalmology, orbital tumors, thyroid eye disease and Von Hippel-Lindau (VHL) and his research interests include orbital tumors and optic nerve disease. He has authored or co-authored over 420 articles, 80 chapters, and 12 books, one of which is Walsh and Hoyt’s Clinical Neuro-Ophthalmology, a major textbook in the field. He is past President of the North American Neuro-Ophthalmology Society and three-time President of the International Neuro-Ophthalmology Society.
Representative Publications:
Acute Transient Oculomotor Nerve Palsy From Presumed Cavernous Angioma in an Infant
POLR3A Variants in Hereditary Spastic Paraplegia and Ataxia
Related Content
-
Coping Psychologically with Thyroid Eye Diseasehttps://www.youtube.com/watch?v=A-pjRWHj...
-
Graves’ OrbitopathyEpidemiology: Eye complications occur i...
-
Anthony Maloof, MBBS hons, MBiomedE, FRANZCODr. Maloof is an internationally recogni...
-
What Causes Bulging Eyes?Having remarkably protruding eyes disrup...
-
Mario Salvi, MDDr. Mario Salvi is a specialist in endoc...
-
Mycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
-
Clinical Characteristics of Patients Requiring a Second Dose of Radioactive Iodine for the Treatment of Graves’ Di...Graves’ disease is an autoimmune condi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.